Trade-offs in Oral Drug Product Development
نویسندگان
چکیده
منابع مشابه
Time-Cost Trade-Offs in Overlapped Product Development
Increasingly shorter product life cycles impel rms to design, develop, and market more products in less time than ever before. Overlapping of design and development stages is commonly regarded as the most promising strategy to reduce product development times. However, overlapping typically requires additional resources and can be costly. Our research addresses the trade-o) between product deve...
متن کاملTrade-offs
23. Stent, G.S. (1972). Prematurity and uniqueness in scientific discovery. Sci. Am. 227, 84–93. 24. Mirsky, A.E., and Pollister, A.W. (1946). Chromosin, a desoyribose nucleoprotein complex of the cell nucleus. J. Gen. Physiol. 30, 117–148. 25. Boivin, A. (1947). Directed mutation in colon bacilli, by an inducing principle of desoxyribonucleic nature: Its meaning for the general biochemistry of...
متن کاملTrade-offs in Thailand.
P roteomics is defined as the protein complement of the genome and involves the complete analysis of all the proteins in a given sample [1,2]. Several technologies are involved, and numerous questions concerning the proteins are addressed. What proteins are contained in a biological sample? At what concentration do the proteins exist? How do protein expression levels alter in different samples?...
متن کاملForest Product Trade Impacts of an Invasive Species : Mode ing Structure and Intervention Trade - offs
Asian gypsy and nun moth ~ntroductlons Into the Unrted States. possrbly arriting 011 imposted Slbertarl coniferous logs, threaten don~estrc forests and product ~narkets and could habe global market consequences. We simulate, using the Global Forest Products Model ( a spatial equilibrium model of* the morld forest sector), the consequences under current policles of a wtdespread, s~iccessful pest...
متن کاملTrade-offs in mass spectrometry.
When should a new instrumental technique or analytical method be adopted for use in clinical chemical analyses? Many clinical methods are approved by the FDA based on the 510 k process, which requires demonstration that a new test is at least as good as those already in the marketplace. This is justified from both a scientific and free-market regulatory perspective when replacement of a sound m...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: YAKUGAKU ZASSHI
سال: 2015
ISSN: 0031-6903,1347-5231
DOI: 10.1248/yakushi.14-00228-2